Back to search

Article

Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy induced peripheral neuropathy

2022-07-13

Abstract excerpt

<title>Abstract</title> <p>Dose-limiting toxicities significantly impact the benefit/risk profile of many drugs. Whole genome sequencing (WGS) in patients receiving drugs with dose-limiting toxicities can identify therapeutic hypotheses to prevent these toxicities. Peripheral neuropathy (PN) is a common dose-limiting neurological toxicity of chemotherapies with no effective approach for prevention. We conducted a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ae66efc-6802-5ae9-9392-260ba90c330c
DOI
10.21203/rs.3.rs-1816977/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy induced peripheral neuropathyDOI 10.21203/rs.3.rs-1816977/v1
Select a neighboring publication to make it the new centre.